Ben tells us about making very small interfaces, well-tolerated in the body, and applying it to one of humankind’s most significant health issues - cancer.
It is always so exciting to talk to very early-stage innovators – their passion is so evident and Opto has the makings of being a very important company in the bioelectronics space. We also discuss how leveraging the Cambridge ecosystem works, but thinking scale and globally from the outset.
Tune in next week for a special interview with Dr Hermann Hauser.
If you are enjoying our show notes, register to get notified by email when new show notes are published.
To listen and subscribe, search for ‘Cambridge Tech Podcast’ on your favourite podcasting platform or visit cambridgetechpodcast.com.